Product analysis · serum · Peach Slices
Redness Relief Azelaic Acid Serum
Peach Slices describes this serum with 10% azelaic acid and redness-focused positioning. The report distinguishes serum-specific manufacturer wording from collection-level claims and keeps historical concern outcomes separate from redness-specific evidence.
The retained skin-tolerance cell has both positive and negative contributions; it is not a count of people or a reaction rate. Manufacturer study figures have missing protocol details and do not establish an individual result.
The manufacturer also positions this serum for sensitive, reactive skin. These are manufacturer labels.
Sensitive/reactive positioning does not establish individual tolerance or a no-reaction promise; historical formula continuity is unverified. Historical skin-tolerance counts include 71 negative and 28 positive contributions; these are not people or personal reaction rates.
The manufacturer describes visible redness and irritation relief, gentle exfoliation, blemish concerns and more even-looking tone/texture.
Concentration and benefits are manufacturer claims; no independent concentration assay or clinical-treatment result was verified.
The manufacturer lists azelaic acid, panthenol and cica/algae ingredients and explicitly uses these free-from labels.
Manufacturer labels are not independent certification or personal safety. The saved catalog splits an ingredient name; this does not establish reformulation or historical continuity.
Five selected corrected cells show both positive and negative directions. The broad concern-performance cell covers multiple concerns; it cannot be read as 97 redness results.
- Concern-specific outcomes: 80 positive · 17 negative · 97 classified mentions
- Product texture and absorption: 18 positive · 3 negative · 21 classified mentions
- Value and amount: 13 positive · 7 negative · 20 classified mentions
- Routine compatibility: 11 positive · 4 negative · 15 classified mentions
Classified mentions in the retained subset; these counts are not ratings or unique buyers.
Contributing sources run July 10, 2022 to March 24, 2026. Counts are source/dimension contributions, not people, reaction rates, measured efficacy or current-formula proof. The 97 concern contributions are not all specifically about redness.
The broad skin-tolerance cell includes both directions. It does not identify a symptom, cause or individual risk.
- Skin tolerance: 28 positive · 71 negative · 99 classified mentions
Classified mentions in the retained subset; these counts are not ratings or unique buyers.
The 99 skin-tolerance contributions are historical reports, not counts of people or personal reaction rates. Only the five selected cells are shown; retained coverage does not establish absence of other concerns.
Single-asterisk study figures refer to this serum; double-asterisk figures refer to the Redness Relief Collection. Collection results cannot be assigned to the serum alone.
No readable denominator, date, duration, protocol, tested dose or comparator. Manufacturer percentages do not establish measured individual benefit or verified clinical efficacy.
Apply to clean, dry skin, then moisturizer; use SPF during daytime. The manufacturer permits AM and PM use up to twice daily.
Up to twice daily is an optional maximum, not a mandatory routine. A measured dose and full warning panel were not established.
The focal manufacturer size label reads 30ML. No measured application dose or fixed daily use count establishes bottle life.
No calculated uses/days, fluid-ounce conversion, historical pack continuity, selected retailer size, complete live range or current stock is verified.
Sources and dates
Source observation dates are shown separately from the editorial review date.
- Focal manufacturer facts, captured October 19, 2026 · Current brand information ·
- Historical retained feedback, earliest contributing source · Historical feedback · retained subset ·
- Historical retained feedback, latest contributing source · Historical feedback · retained subset ·
First published: (Pacific time). Updated: (Pacific time). Editorial dates do not refresh historical evidence.
Full evidence and limits
- Manufacturer information was captured October 19, 2026; historical feedback spans July 2022 to March 2026. Historical formula, lot, pack and retailer-SKU continuity are unknown.
- Counts are source/dimension contributions, not people, measured efficacy or personal safety. Broad concern mentions are not all redness-specific.
- The manufacturer’s study claims lack readable denominators and full protocols; collection-level results are not attributed to the serum.
- No measured dose supports a bottle-duration estimate. Current selected pack and stock are unverified; no qualified alternative or purchase link is offered.